Impact of initiating long-acting injectable antipsychotics on hospitalization in patients with bipolar I disorder
Related Experiment Video
Updated: Feb 6, 2026

Developing a Rat Model for Bipolar Disorder
Published on: May 2, 2025
Tingjian Yan1, Mallik Greene2, Eunice Chang1
1Health Services Research, Partnership for Health Analytic Research, LLC, Beverly Hills, CA, 90212 USA.
Aim:
To compare risk of hospitalization in patients with bipolar I disorder (BD-I) initiating long-acting injectable antipsychotics (LAIs).
Materials & Methods:
Using Truven Health Analytics MarketScan® (Medicaid, Commercial and Medicare Supplemental) databases (2012-2016), patients (≥18 years) with BD-I with a LAI (aripiprazole once monthly [AOM 400], fluphenazine-LAI, haloperidol-LAI, risperidone-LAI and paliperidone-4-week-LAI) were identified.
Results:
The adjusted odds of having hospitalization were significantly higher in haloperidol-LAI (Odds ratio [95% CI]: 1.39 [1.03-1.87] all-cause; p = 0.029; 1.41 [1.03-1.93] psychiatric-specific; p = 0.032) and risperidone-LAI (1.54 [1.12-2.13]; p = 0.009; 1.68 [1.20-2.37]; p = 0.003) users versus AOM 400 users. Risks of hospitalization did not differ comparing fluphenazine-LAI and paliperidone-LAI users with AOM 400 users.
Conclusion:
AOM 400 may be more beneficial at reducing hospitalization rates in BD-I versus haloperidol-LAI and risperidone-LAI.
Related Concept Videos
Bipolar Disorder
Hospitals-II
Nurses that work in...
Hospitals-I
Initiation of Translation
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
Initiation of Translation
Forces Acting on Chromosomes
Microtubules and motor proteins exert two types of forces on...

